Rachner TD - Search Results

1

Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification.

Di Bartolo BA, Schoppet M, Mattar MZ, Rachner TD, Shanahan CM, Kavurma MM. Di Bartolo BA, et al. Among authors: rachner td. Cardiovasc Res. 2011 Aug 1;91(3):537-45. doi: 10.1093/cvr/cvr084. Epub 2011 Mar 29. Cardiovasc Res. 2011. PMID: 21447702

2

17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7.

Rachner TD, Schoppet M, Niebergall U, Hofbauer LC. Rachner TD, et al. Biochem Biophys Res Commun. 2008 Apr 11;368(3):736-41. doi: 10.1016/j.bbrc.2008.01.118. Epub 2008 Feb 4. Biochem Biophys Res Commun. 2008. PMID: 18252198

3

Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.

Rachner TD, Benad P, Rauner M, Goettsch C, Singh SK, Schoppet M, Hofbauer LC. Rachner TD, et al. J Cell Biochem. 2009 Sep 1;108(1):106-16. doi: 10.1002/jcb.22232. J Cell Biochem. 2009. PMID: 19544400

4

Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.

Rachner TD, Singh SK, Schoppet M, Benad P, Bornhäuser M, Ellenrieder V, Ebert R, Jakob F, Hofbauer LC. Rachner TD, et al. Cancer Lett. 2010 Jan 1;287(1):109-16. doi: 10.1016/j.canlet.2009.06.003. Epub 2009 Jul 3. Cancer Lett. 2010. PMID: 19577359

5

Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study.

Szulc P, Schoppet M, Rachner TD, Chapurlat R, Hofbauer LC. Szulc P, et al. Among authors: rachner td. J Clin Endocrinol Metab. 2014 Feb;99(2):617-24. doi: 10.1210/jc.2013-3201. Epub 2013 Nov 25. J Clin Endocrinol Metab. 2014. PMID: 24276456

6

Seizures associated with zoledronic acid for osteoporosis.

Tsourdi E, Rachner TD, Gruber M, Hamann C, Ziemssen T, Hofbauer LC. Tsourdi E, et al. Among authors: rachner td. J Clin Endocrinol Metab. 2011 Jul;96(7):1955-9. doi: 10.1210/jc.2011-0418. Epub 2011 Apr 20. J Clin Endocrinol Metab. 2011. PMID: 21508139

7

Dickkopf-1 as a mediator and novel target in malignant bone disease.

Rachner TD, Göbel A, Benad-Mehner P, Hofbauer LC, Rauner M. Rachner TD, et al. Cancer Lett. 2014 May 1;346(2):172-7. doi: 10.1016/j.canlet.2014.01.010. Epub 2014 Jan 22. Cancer Lett. 2014. PMID: 24462802 Review.

8

High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.

Rachner TD, Thiele S, Göbel A, Browne A, Fuessel S, Erdmann K, Wirth MP, Fröhner M, Todenhöfer T, Muders MH, Kieslinger M, Rauner M, Hofbauer LC. Rachner TD, et al. BMC Cancer. 2014 Sep 2;14:649. doi: 10.1186/1471-2407-14-649. BMC Cancer. 2014. PMID: 25182503 Free PMC article.

9

Challenges in Preventing Bone Loss Induced by Aromatase Inhibitors.

Rachner TD, Göbel A, Jaschke NP, Hofbauer LC. Rachner TD, et al. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa463. doi: 10.1210/clinem/dgaa463. J Clin Endocrinol Metab. 2020. PMID: 32674135 Review.

10

Circulating Dickkopf1 Parallels Metabolic Adaptations and Predicts Disease Trajectories in Patients With COVID-19.

Jaschke NP, Funk AM, Jonas S, Riffel RM, Sinha A, Wang A, Pählig S, Hofmann M, Altmann H, Von Bonin S, Koch T, Spieth P, Tausche K, Akgün K, Rauner M, Kronstein-Wiedemann R, Odendahl M, Tonn T, Göbel A, Hofbauer LC, Rachner TD. Jaschke NP, et al. Among authors: rachner td. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3370-3377. doi: 10.1210/clinem/dgac514. J Clin Endocrinol Metab. 2022. PMID: 36071553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page